Trials / Unknown
UnknownNCT05877274
Sodium Channel Mutations in Patient With the Anterior Cutaneous Nerve Entrapment Syndrome (ACNES)
Sodium Channel Mutations (SCN9A, SCN10A) in the Anterior Cutaneous Nerve Entrapment Syndrome (ACNES)
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 50 (estimated)
- Sponsor
- Maxima Medical Center · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The goal of this observational study is to learn about sodium channel (Nav) mutations in patients with the Anterior Cutaneous Nerve Entrapment Syndrome (ACNES). This study will give more insight into the pathophysiology of ACNES, which is still largely unknown. The primary objective is to determine if there are mutations of Nav1.7 and Nav1.8 in patients with ACNES. Therefore, one blood sample will be drawn, in which the mutations will be analyzed.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Sodium channel mutation | Mutation of the genes SCN9A and SCN10A, which encode for Sodium channel 1.7 and 1.8. |
Timeline
- Start date
- 2023-10-03
- Primary completion
- 2024-06-01
- Completion
- 2024-12-01
- First posted
- 2023-05-26
- Last updated
- 2023-10-30
Locations
1 site across 1 country: Netherlands
Source: ClinicalTrials.gov record NCT05877274. Inclusion in this directory is not an endorsement.